Abstract:The cells isolated from biopsy specimen of a patient with alcoholic liver cirrhosis and cultured under standard conditions for obtaining stromal cell culture clearly diverged during early passages into two morphologically and phenotypically different subtypes: epithelial and mesenchymal. Mesenchymal cells expressed CD90 and CD44 and epithelial cells expressed CD166, CD227, and hepatocyte growth factor receptor Met. Starting from passage 6, the culture underwent spontaneous morphological changes and by passages… Show more
“…We [29], as well as other authors [30,31], obtained liver MSCs from liver biopsy material by tissue disintegration and subsequent processing with collagenase. The resulting cell suspension, without any additional manipulations, was placed in uncoated culture flasks and incubated in the medium for the cultivation of MSCs (DMEM + 10–20% FBS).…”
Section: Methods Of Isolation Of Human Liver Mscsmentioning
confidence: 99%
“…Our gene expression microarray data show that MSCs isolated from the liver of patients with fibrosis or cirrhosis express several liver-specific genes: ribonuclease RNase A family 4 ( RNASE4 ), CYP1A2 , γ-glutamyl transpeptidase ( GGT1 ), and glutamine synthase ( GLUL )—at a low level; CYP1B1 —at a relatively high level; a very high level of expression was observed only for the NNMT gene encoding the nicotinamide N -methyltransferase. Albumin, α-phetoprotein ( AFP ), and hepatocyte nuclear factor-4 ( HNF4A ) were not expressed in our liver MSCs both at the protein level [29] and at the mRNA level. At the same time, expression of the c-Met hepatocyte growth factor receptor was detected by us in 60% of cells in the liver MSC population by flow cytometry [29] as well as at the transcriptome level (see Table 1).…”
Section: Morphology and Phenotype Of Human Liver Mscsmentioning
confidence: 99%
“…Albumin, α-phetoprotein ( AFP ), and hepatocyte nuclear factor-4 ( HNF4A ) were not expressed in our liver MSCs both at the protein level [29] and at the mRNA level. At the same time, expression of the c-Met hepatocyte growth factor receptor was detected by us in 60% of cells in the liver MSC population by flow cytometry [29] as well as at the transcriptome level (see Table 1).…”
Section: Morphology and Phenotype Of Human Liver Mscsmentioning
Chronic liver diseases constitute a significant economic, social, and biomedical burden. Among commonly adopted approaches, only organ transplantation can radically help patients with end-stage liver pathologies. Cell therapy with hepatocytes as a treatment for chronic liver disease has demonstrated promising results. However, quality human hepatocytes are in short supply. Stem/progenitor cells capable of differentiating into functionally active hepatocytes provide an attractive alternative approach to cell therapy for liver diseases, as well as to liver-tissue engineering, drug screening, and basic research. The application of methods generally used to isolate mesenchymal stem cells (MSCs) and maintain them in culture to human liver tissue provides cells, designated here as liver MSCs. They have much in common with MSCs from other tissues, but differ in two aspects—expression of a range of hepatocyte-specific genes and, possibly, inherent commitment to hepatogenic differentiation. The aim of this review is to analyze data regarding liver MSCs, probably another type of liver stem/progenitor cells different from hepatic stellate cells or so-called hepatic progenitor cells. The review presents an analysis of the phenotypic characteristics of liver MSCs, their differentiation and therapeutic potential, methods for isolating these cells from human liver, and discusses issues of their origin and heterogeneity. Human liver MSCs are a fascinating object of fundamental research with a potential for important practical applications.
“…We [29], as well as other authors [30,31], obtained liver MSCs from liver biopsy material by tissue disintegration and subsequent processing with collagenase. The resulting cell suspension, without any additional manipulations, was placed in uncoated culture flasks and incubated in the medium for the cultivation of MSCs (DMEM + 10–20% FBS).…”
Section: Methods Of Isolation Of Human Liver Mscsmentioning
confidence: 99%
“…Our gene expression microarray data show that MSCs isolated from the liver of patients with fibrosis or cirrhosis express several liver-specific genes: ribonuclease RNase A family 4 ( RNASE4 ), CYP1A2 , γ-glutamyl transpeptidase ( GGT1 ), and glutamine synthase ( GLUL )—at a low level; CYP1B1 —at a relatively high level; a very high level of expression was observed only for the NNMT gene encoding the nicotinamide N -methyltransferase. Albumin, α-phetoprotein ( AFP ), and hepatocyte nuclear factor-4 ( HNF4A ) were not expressed in our liver MSCs both at the protein level [29] and at the mRNA level. At the same time, expression of the c-Met hepatocyte growth factor receptor was detected by us in 60% of cells in the liver MSC population by flow cytometry [29] as well as at the transcriptome level (see Table 1).…”
Section: Morphology and Phenotype Of Human Liver Mscsmentioning
confidence: 99%
“…Albumin, α-phetoprotein ( AFP ), and hepatocyte nuclear factor-4 ( HNF4A ) were not expressed in our liver MSCs both at the protein level [29] and at the mRNA level. At the same time, expression of the c-Met hepatocyte growth factor receptor was detected by us in 60% of cells in the liver MSC population by flow cytometry [29] as well as at the transcriptome level (see Table 1).…”
Section: Morphology and Phenotype Of Human Liver Mscsmentioning
Chronic liver diseases constitute a significant economic, social, and biomedical burden. Among commonly adopted approaches, only organ transplantation can radically help patients with end-stage liver pathologies. Cell therapy with hepatocytes as a treatment for chronic liver disease has demonstrated promising results. However, quality human hepatocytes are in short supply. Stem/progenitor cells capable of differentiating into functionally active hepatocytes provide an attractive alternative approach to cell therapy for liver diseases, as well as to liver-tissue engineering, drug screening, and basic research. The application of methods generally used to isolate mesenchymal stem cells (MSCs) and maintain them in culture to human liver tissue provides cells, designated here as liver MSCs. They have much in common with MSCs from other tissues, but differ in two aspects—expression of a range of hepatocyte-specific genes and, possibly, inherent commitment to hepatogenic differentiation. The aim of this review is to analyze data regarding liver MSCs, probably another type of liver stem/progenitor cells different from hepatic stellate cells or so-called hepatic progenitor cells. The review presents an analysis of the phenotypic characteristics of liver MSCs, their differentiation and therapeutic potential, methods for isolating these cells from human liver, and discusses issues of their origin and heterogeneity. Human liver MSCs are a fascinating object of fundamental research with a potential for important practical applications.
“…It should be noted, that there are discrepancies in the data presented by authors in the literature concerning the pattern of markers expressed by epithelial and mesenchymal afterbirth cells [109,181]. Native human afterbirth cells share some phenotypic features comparable with human hepatic multipotent stem cells (hHpSC) and bipotent hepatoblasts: EpCAM, CK19, CD133 [17,27,35,181], adult multipotent stem cells expressing mesenchymal markers: CD44, CD73, CD90, CD105, CK19, SSEA-4, NANOG, OCT-4 [15,52,66,67,181,[53][54][55][56][57][58][59][60] and adult bipotent hepatic progenitor cells (HPC): DLK-1 [78,184]. EpCAM expression, characteristic of hepatoblasts, but not of mesenchymal liver cells, has been confirmed in afterbirth cells only in few studies [181,[183][184][185].…”
Toxic, viral and surgical injuries can pose medical indications for liver transplantation. The number of patients waiting for a liver transplant still increases, but the number of organ donors is insufficient. Hepatocyte transplantation was suggested as a promising alternative to liver transplantation, however, this method has some significant limitations. Currently, afterbirth tissues seem to be an interesting source of cells for the regenerative medicine, because of their unique biological and immunological properties. It has been proven in experimental animal models, that the native stem cells, and to a greater extent, hepatocyte-like cells derived from them and transplanted, can accelerate regenerative processes and restore organ functioning. The effective protocol for obtaining functional mature hepatocytes in vitro is still not defined, but some studies resulted in obtaining functionally active hepatocyte-like cells. In this review, we focused on human stem cells isolated from placenta and umbilical cord, as potent precursors of hepatocyte-like cells for regenerative medicine. We summarized the results of preclinical and clinical studies dealing with the introduction of epithelial and mesenchymal stem cells of the afterbirth origin to the liver failure therapy. It was concluded that the use of native afterbirth epithelial and mesenchymal cells in the treatment of liver failure could support liver function and regeneration. This effect would be enhanced by the use of hepatocyte-like cells obtained from placental and/or umbilical stem cells.
“…Jones et al [24] reported that bovine BMSCs are positive for expression of CD166. In addition, bovine LMSCs are negative for expression of CD166 but positive for expression of CD44, CD29, CD73, CD90, and CD106 [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43]. +( 32)…”
LMSCs and BMSCs from other speciesIn mice, LMSCs and BMSCs have nearly identical markers since both cell types are positive for CD44, CD29 CD105, CD49e, CD90 and Sca-1. However, mouse LMSCs are positive for CD73 [21], and mouse BMSCs have low expression of CD73 [22]. In rats, there are no studies on LMSCs; however, Payushina et al.[23] indicated that LMSCs are positive for expression of CD90.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.